These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12529114)

  • 1. Summaries for patients. Risk factors and treatment in women with coronary artery disease.
    Ann Intern Med; 2003 Jan; 138(2):I10. PubMed ID: 12529114
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study.
    Vittinghoff E; Shlipak MG; Varosy PD; Furberg CD; Ireland CC; Khan SS; Blumenthal R; Barrett-Connor E; Hulley S;
    Ann Intern Med; 2003 Jan; 138(2):81-9. PubMed ID: 12529088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of acute coronary syndromes.
    Schulman SP; Fessler HE
    Am J Respir Crit Care Med; 2001 Sep; 164(6):917-22. PubMed ID: 11587971
    [No Abstract]   [Full Text] [Related]  

  • 4. Status of secondary prevention in patients undergoing coronary revascularization.
    Allen JK; Blumenthal RS; Margolis S; Young DR
    Am J Cardiol; 2001 May; 87(10):1203-6: A7. PubMed ID: 11356400
    [No Abstract]   [Full Text] [Related]  

  • 5. Reperfusion for acute myocardial infarction: is the future in plastics?
    Rao SV; Jollis JG
    Mayo Clin Proc; 2000 Oct; 75(10):991-3. PubMed ID: 11040845
    [No Abstract]   [Full Text] [Related]  

  • 6. Current therapies for secondary prevention after myocardial infarction.
    Cannon CE; Smith SC
    Curr Opin Cardiol; 1999 Mar; 14(2):155-60. PubMed ID: 10191975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening and management of coronary artery disease in diabetic patients].
    Kraiem S; Abassi C; Annabi N; Smaali I; Issaa I; Wali M; Malou M; Hannachi S; Longo S; Battikh K; Slimane ML
    Tunis Med; 2006 Oct; 84(10):670-6. PubMed ID: 17193866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary prevention in chronic coronary heart disease].
    Hunziker P; Bertel O
    Schweiz Med Wochenschr; 1997 Feb; 127(7):254-60. PubMed ID: 9157530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary prevention in acute myocardial infarction.
    Mehta RH; Eagle KA
    BMJ; 1998 Mar; 316(7134):838-42. PubMed ID: 9549457
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular protection and prevention in patients with cardiac conditions and diabetes].
    Charpentier G; Puel J; Steg PG
    Presse Med; 2005 Oct; 34(18):1295-8. PubMed ID: 16269992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing the prescription of statins after an acute coronary syndrome: the influence of coronary angioplasty and total cholesterol levels.
    Ferrières J; Danchin N; Grenier O; Cantet C; Thomas D; Cambou JP
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):559-60. PubMed ID: 11916367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Secondary prevention of acute coronary syndromes: are we following correctly the guidelines?].
    Casella G; Greco C; Maggioni AP; Di Pasquale G
    G Ital Cardiol (Rome); 2006 Mar; 7(3):176-85. PubMed ID: 16572983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention of coronary heart disease in the elderly.
    Bulpitt CJ
    Heart; 2005 Mar; 91(3):396-400. PubMed ID: 15710740
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relationship between mortality due to acute myocardial infarction and adherence to clinical guidelines].
    Coma-Canella I
    Rev Esp Cardiol; 2006 Mar; 59(3):189-92. PubMed ID: 16712740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Survival after myocardial infarction in the nineties. Results of a prospective registry and their implications as to identification of an increased risk of death and especially sudden death].
    Jordaens L; Tavernier R
    J Med Liban; 1999; 47(3):181-9. PubMed ID: 10550944
    [No Abstract]   [Full Text] [Related]  

  • 16. Trial is needed of ACE inhibitors plus beta blockers in survivors of myocardial infarction.
    McAlister FA
    BMJ; 1998 Sep; 317(7160):751. PubMed ID: 9732353
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination drug therapy after myocardial infarction. Early aldosterone blocking protects risk patients].
    MMW Fortschr Med; 2006 Jun; 148(24):48-9. PubMed ID: 16850812
    [No Abstract]   [Full Text] [Related]  

  • 18. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
    EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
    Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary prevention of ischemic cardiopathy].
    Caruzzo E; Caruzzo C
    Cardiologia; 1995 May; 40(5):347-53. PubMed ID: 8529246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.